Jayshree Shah, from John Theurer Cancer Center, on the Safety and Efficacy of Nilotinib for Patients With CML
Jayshree Shah, RN, APN-C, MSN, BSN, BS
Advertisement
Articles by Jayshree Shah, RN, APN-C, MSN, BSN, BS
Myelodysplastic syndromes (MDS) are a group of hematological conditions affecting the blood stem cells in the bone marrow.
Advertisement
Latest Updated Articles
Jayshree Shah on the Safety and Efficacy of NilotinibPublished: May 2nd 2012 | Updated:
Case Presentation: Myelodysplastic SyndromesPublished: October 13th 2011 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
2
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
3
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
4
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
5